Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug therapy for adults with Kashin-Beck disease
ChiCTR-TRC-09000395Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of celecoxib, meloxicam, glucosamine sulphate, diacerein, naproxen and 1 more in Kashin-Beck disease (KBD) (7 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Western Ontario and McMaster Universities Osteoarthritis Index and Visual analogue pain scale. Started Sep 2014; status: completed.
02
Drugs
celecoxibmeloxicamglucosamine sulphatediacereinnaproxen
03
Conditions
Kashin-Beck disease (KBD)
Beyond the preview
Go deeper on ChiCTR-TRC-09000395.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000395.